Publication:
Tocilizumab as a possible cause of ischemic colitis.

Simple item page
dc.contributor.authorForneiro Pérez, Rocío
dc.contributor.authorDabán López, Pablo
dc.contributor.authorZurita Saavedra, María Sol
dc.contributor.authorHernández García, María Dolores
dc.contributor.authorMirón Pozo, Benito
dc.date.accessioned2023-02-09T09:48:02Z
dc.date.available2023-02-09T09:48:02Z
dc.date.issued2020-11-13
dc.identifier.doi10.1016/j.gastrohep.2020.07.016
dc.identifier.essn0210-5705
dc.identifier.pmcPMC7661921
dc.identifier.pmid33190937
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661921/pdf
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.gastrohep.2020.07.016
dc.identifier.urihttp://hdl.handle.net/10668/16602
dc.issue.number5
dc.journal.titleGastroenterologia y hepatologia
dc.journal.titleabbreviationGastroenterol Hepatol
dc.language.isoen
dc.language.isoes
dc.organizationHospital Universitario San Cecilio
dc.organizationHospital Universitario San Cecilio
dc.page.number373-374
dc.pubmedtypeCase Reports
dc.rights.accessRightsopen access
dc.subject.meshAntibodies, Monoclonal, Humanized
dc.subject.meshCOVID-19
dc.subject.meshColitis, Ischemic
dc.subject.meshColonoscopy
dc.subject.meshGastrointestinal Hemorrhage
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshRectum
dc.subject.meshCOVID-19 Drug Treatment
dc.titleTocilizumab as a possible cause of ischemic colitis.
dc.title.alternativeTocilizumab como posible causa de colitis isquémica.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number44
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
PMC7661921.pdf
Size:
785.42 KB
Format:
Adobe Portable Document Format
Download

Collections

SAS - Hospital Universitario San Cecilio

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía